Literature DB >> 28160237

Management of patients presenting with haemoptysis to a Tertiary Care Italian Emergency Department: the Florence Haemoptysis Score (FLHASc).

Simone Vanni1, Simone Bianchi2, Sofia Bigiarini2, Claudia Casula2, Marco Brogi3, Stefano Orsi4, Manlio Acquafresca5, Lorenzo Corbetta6, Stefano Grifoni2.   

Abstract

We analysed the clinical features and diagnostic workup of patients presenting with haemoptysis to an Italian teaching hospital to derive an easy-to-use clinical score to guide risk stratification and initial management in the emergency department (ED). We retrospectively reviewed clinical records of consecutive patients with haemoptysis over 1 year. A pre-specified set of variables, including demographic data, vital signs, type of expectorate (pure blood vs. blood-streaked sputum), comorbidities, and diagnostic tests and treatments was originally registered. The primary outcome was a composite of any of the following: death from any cause, invasive or non-invasive ventilation, Intensive Care Unit admission, blood transfusions or invasive haemostatic procedures. We investigated associations between the pre-specified clinical variables and the primary outcome using a logistic regression analysis. Finally, we derived a score (the Florence Haemoptysis Score, FLHASc) giving a proportional weight to each variable according to the Odds Ratios (OR). We included 197 patients with a median age of 60 years. The first radiological study was a plain chest X-ray in 128 patients (65%). For 33 (17%) patients, a chest computer tomography (CT scan) was the first radiological study. The most common diagnosis was lung malignancy (19% of cases). The diagnosis remained undetermined in one-third of patients. The primary outcome was met by 11.2% of the study population. Systolic blood pressure <100 mmHg (OR 9.7), a history of malignancy (OR 3), the expectoration of pure blood (OR 2.8), and more than 2 episodes of haemoptysis in the prior 24 h (OR 2.5) are found as independent predictors of the primary outcome. The FLHASc ranges from 0 to 6 with a prognostic accuracy of 78% (IC 95%, 68-88%). The primary outcome incidence is 2.4% (IC 95%, 0.2-8.2%) in patients with a FLHASc equal to zero (n = 85, 43%) versus 13.4% (IC 95% 7.8-21.1%) in patients with a FLHASc > 0 (p < 0.01). Among patients with a FLHASc equal to zero, a negative chest X-ray study identifies patients who may be safely discharged. Patients who presented to the ED with haemoptysis experience a heterogeneous management. We derive a simple clinical prognostic score that may rationalize their diagnostic workup.

Entities:  

Keywords:  Clinical score; Diagnosis; Emergency department; Haemoptysis; Prognosis

Mesh:

Year:  2017        PMID: 28160237     DOI: 10.1007/s11739-017-1618-8

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  21 in total

Review 1.  Clinical assessment and management of massive hemoptysis.

Authors:  E Jean-Baptiste
Journal:  Crit Care Med       Date:  2000-05       Impact factor: 7.598

Review 2.  Role of bronchoscopy in massive hemoptysis.

Authors:  R A Dweik; J K Stoller
Journal:  Clin Chest Med       Date:  1999-03       Impact factor: 2.878

3.  Early prediction of in-hospital mortality of patients with hemoptysis: an approach to defining severe hemoptysis.

Authors:  Muriel Fartoukh; Babak Khoshnood; Antoine Parrot; Antoine Khalil; Marie-France Carette; Annabelle Stoclin; Charles Mayaud; Jacques Cadranel; Pierre Yves Ancel
Journal:  Respiration       Date:  2011-10-19       Impact factor: 3.580

4.  Color-coding triage and allergic reactions in an Italian ED.

Authors:  Fabio Fabbian; Roberto Melandri; Gabriella Borsetti; Emanuele Micaglio; Marco Pala; Alfredo De Giorgi; Alessandra Mellozzi Menegatti; Arrigo Boccafogli; Roberto Manfredini
Journal:  Am J Emerg Med       Date:  2012-06       Impact factor: 2.469

Review 5.  [Severe haemoptysis: indications for triage and admission to hospital or intensive care unit].

Authors:  M Fartoukh
Journal:  Rev Mal Respir       Date:  2010-10-30       Impact factor: 0.622

Review 6.  Massive hemoptysis: an update on the role of bronchoscopy in diagnosis and management.

Authors:  L Sakr; H Dutau
Journal:  Respiration       Date:  2010-01-08       Impact factor: 3.580

7.  Massive haemoptysis: the definition should be revised.

Authors:  W H Ibrahim
Journal:  Eur Respir J       Date:  2008-10       Impact factor: 16.671

8.  Updated Manchester triage system published this month.

Authors:  Nick Lipley
Journal:  Emerg Nurse       Date:  2005-11-01

Review 9.  Pathogenesis, evaluation, and therapy for massive hemoptysis.

Authors:  A B Thompson; H Teschler; S I Rennard
Journal:  Clin Chest Med       Date:  1992-03       Impact factor: 2.878

10.  Exsanguinating hemoptysis.

Authors:  A A Garzon; M M Cerruti; M E Golding
Journal:  J Thorac Cardiovasc Surg       Date:  1982-12       Impact factor: 5.209

View more
  3 in total

Review 1.  Approach to Hemoptysis in the Modern Era.

Authors:  Sébastien Gagnon; Nicholas Quigley; Hervé Dutau; Antoine Delage; Marc Fortin
Journal:  Can Respir J       Date:  2017-12-21       Impact factor: 2.409

2.  Efficacy, safety and usability of bronchial artery embolization using a new anti-reflux microcatheter in the management of haemoptysis.

Authors:  Salvatore Alessio Angileri; Giovanni Maria Rodà; Antonio Arrichiello; Giulia Signorelli; Letizia Di Meglio; Martina Gurgitano; Francesco Di Bartolomeo; Anna Maria Ierardi; Aldo Paolucci; Gianpaolo Carrafiello
Journal:  Acta Biomed       Date:  2020-09-23

3.  Long-term prognostic outcomes in patients with haemoptysis.

Authors:  Michele Mondoni; Paolo Carlucci; Giuseppe Cipolla; Matteo Pagani; Francesco Tursi; Alessandro Fois; Pietro Pirina; Sara Canu; Stefano Gasparini; Martina Bonifazi; Silvia Marani; Andrea Comel; Laura Saderi; Sabrina De Pascalis; Fausta Alfano; Stefano Centanni; Giovanni Sotgiu
Journal:  Respir Res       Date:  2021-08-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.